Search clinical trials for: Positive Technologies

Total 13348 results

University Hospital, Toulouse

Recruiting

Neurofeedback-EEG Rehabilitation Protocol on Motor Recovery in the Subacute Phase Post-stroke (CUSTOM-NF-STROKE)

Cerebrovascular Accident

France
NanoPin Technologies, Inc.
Fortrea

Not yet recruiting

Clinical Evaluation of the NanoDetect-TB Mycobacterium Tuberculosis Detection Kit for the Diagnosis of Tuberculosis Disease

Tuberculosis, Pulmonary | Tuberculosis, Extrapulmonary | Tuberculosis Active
Biocad

Recruiting

Clinical Study of the Efficacy and Safety of BCD-178 and Perjeta® as Neoadjuvant Therapy of HER2-Positive Breast Cancer (PREFER)

Breast Cancer

Russian Federation
National Institute of Allergy and Infectious Diseases...
SIGA Technologies

Recruiting

Study of Tecovirimat for Human Monkeypox Virus (STOMP)

Monkeypox | MPOX

United States, Puerto Rico, Brazil, South Africa, Argentina, Mexico, Japan, Thailand, Peru
Jazz Pharmaceuticals
BeiGene, Ltd.

Recruiting

A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers (HERIZON-GEA-01)

Gastroesophageal Adenocarcinoma | Esophageal Adenocarcinoma | Gastric Neoplasms

Korea, Republic of, Belgium, Japan, China, Netherlands, Spain, Germany, United Kingdom, Malaysia, Taiwan, Portugal, France, Italy, Australia, Turkey, Thailand, Argentina, Mexico, Ireland, Estonia, Serbia, Romania, Canada, Poland, Brazil, ... and more
Hoffmann-La Roche

Recruiting

A Study of Atezolizumab Versus Placebo as Adjuvant Therapy in Patients With High-Risk Muscle-Invasive Bladder Cancer Who Are ctDNA Positive Following Cystectomy (IMvigor011)

Muscle-invasive Bladder Cancer

Belgium, Korea, Republic of, Japan, Brazil, China, United States, Singapore, France, United Kingdom, Canada, Greece, Italy, Spain, Turkey, Russian Federation, Ukraine, Israel, Czechia, Colombia, Hong Kong, Argentina, Germany, Ireland, Polan... and more
Koronis Biomedical Technologies

Not yet recruiting

Portable Positive Pressure Therapy Device

COPD
Apollomics Inc.

Recruiting

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors (SPARTA)

Gastric Cancer | Pancreatic Cancer | NSCLC | Lung Cancer | Brain Tumor | Glioblastoma Multiforme | Advanced Cancer | Colon Cancer | Solid Tumors | Thyroid Cancer | Renal Cancer | Gastroesophageal Junction Adenocarcinoma | EGFR Gene Mutation | MET Amplification | HGF | MET Alteration | MET Fusion | Exon 14 Skipping

United States, Spain, France, United Kingdom, Taiwan, Australia, Finland, Italy, Singapore, Hungary, Canada, Puerto Rico, Russian Federation
Merck Sharp & Dohme LLC

Active, not recruiting

A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Standard of Care in Subjects With Previously Treated Metastatic PD-L1 Positive Colorectal Cancer (MK-4280A-007)

Colorectal Cancer

United States, Australia, Canada, Chile, China, Czechia, France, Germany, Israel, Italy, Japan, Korea, Republic of, Malaysia, Norway, Russian Federation, South Africa, Spain, Taiwan, Turkey, Ukraine, United Kingdom
Dilon Technologies Inc.
Syneos Health

Completed

Evaluation of Safety of HEMOBLAST Bellows in Spine Surgery

Surgical Bleeding

United States
Saint Petersburg State University, Russia

Withdrawn

Dabrafenib and Trametinib Combination as a Neoadjuvant Strategy in BRAF-positive Anaplastic Thyroid Cancer (ANAPLAST-NEO)

Thyroid Gland Anaplastic Carcinoma

Russian Federation
British Columbia Cancer Agency
Canadian Cancer Society (CCS); NanoString Technologies, Inc.

Active, not recruiting

Limited Adjuvant Endocrine Therapy for Low Risk Breast Cancer (LALEAST)

Breast Cancer Female | Hormone Receptor Positive Tumor

Canada
Research and Practical Clinical Center for Diagnostics...

Active, not recruiting

AI-based System for Lung Tuberculosis Screening: Diagnostic Accuracy Evaluation

Tuberculosis, Pulmonary

Russian Federation
West German Study Group
Merck Sharp & Dohme LLC; NanoString Technologies, Inc.

Completed

A Study With Pembrolizumab in Combination With Dual Anti-HER2 Blockade With Trastuzumab and Pertuzumab in Early Breast Cancer Patients With Molecular HER2-enriched Intrinsic Subtype (Keyriched-1) (Keyriched-1)

Breast Cancer

Germany
Dissou AFFOLABI
London School of Hygiene and Tropical Medicine; World Health Organization; Institute... and other collaborators

Completed

DIAgnostics for Multidrug Resistant Tuberculosis in Africa (DIAMA)

Tuberculosis, Multidrug-Resistant

Belgium, Benin, Cameroon, Congo, The Democratic Republic of the, Ethiopia, Guinea, Mali, Nigeria, Rwanda, Senegal
New York University
Indiana University; Moi University

Completed

Computerized Counseling to Promote Positive Prevention and HIV Health in Kenya (CARE+ Kenya)

HIV Infections

Kenya
BioStream Technologies, LLC

Completed

Computer-based Social Skills Training for Autism Spectrum Disorder

Autism Spectrum Disorder

United States
ResMed

Unknown

Development of Advanced Leak Detection Technologies for Positive Airway Pressure Devices Therapies

Obstructive Sleep Apnea (OSA)

Australia
American Gene Technologies International Inc.

Unknown

Developing a Functional Cure for HIV Disease: Clinical Specimen Collection From HIV Positive Individuals

HIV Infections

United States
Pfizer

Completed

A Study Of PF-05280586 (Rituximab-Pfizer) Or MabThera® (Rituximab-EU) For The First-Line Treatment Of Patients With CD20-Positive, Low Tumor Burden, Follicular Lymphoma (REFLECTIONS B328-06)

Follicular Lymphoma

United States, Spain, United Kingdom, Korea, Republic of, France, Portugal, India, Mexico, Switzerland, Japan, Germany, Romania, Greece, Austria, Belgium, Italy, Thailand, Croatia, Philippines, Russian Federation, Puerto Rico, Ukr... and more
Biocad

Completed

A Safety and Efficacy Study of BCD-022 With Paclitaxel Compared to Herceptin With Paclitaxel in HER2+ Metastatic Breast Cancer Patients

Human Epithelial Receptor (HER)-2 Positive Breast Cancer

Ukraine, Russian Federation, Belarus, India
Rex Cancer Center, Raleigh, NC
Novartis Pharmaceuticals; Leap of Faith Technologies

Terminated

Telemonitoring Study - for Chronic Myeloid Leukemia (CML)

Chronic Myeloid Leukemia

United States
Pfizer

Completed

A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positive Non Squamous Cancer Of The Lung (PROFILE 1014)

Non Squamous Lung Cancer

United States, Switzerland, Taiwan, Spain, Korea, Republic of, Canada, United Kingdom, Singapore, Japan, Germany, Luxembourg, Australia, France, Brazil, Italy, Hong Kong, China, Belgium, Russian Federation, Austria, Finland, Portugal and more
NanoString Technologies, Inc.

Completed

Prospective Observational Study Evaluating Treatment Decision Impact of Prosigna® in Early Stage Breast Cancer Patients

Breast Cancer

United States
Montreal Heart Institute
Medtronic - MITG; The Montreal Health Innovations Coordinating Center (MHICC)

Completed

Evaluation of Monitoring TECHNOlogies in the PERI-OPerative Care of Cardiac Surgical Patients (TechnoPeriOp)

Postoperative Complications | Respiratory Insufficiency | Acute Kidney Injury | C.Surgical Procedure; Cardiac | Right-Sided Heart Failure

Canada
Universitat Jaume I

Completed

A Positive Psychology Intervention for Fibromyalgia Patients Using ICT´s (BPS_FM)

Chronic Pain | Fibromyalgia

Spain
ImmunoVaccine Technologies, Inc. (IMV Inc.)

Completed

A Phase I Safety Study of a Cancer Vaccine to Treat HLA-A2 Positive Advanced Stage Ovarian, Breast and Prostate Cancer

Breast Neoplasms | Prostatic Neoplasms | Ovarian Neoplasms

United States
Research Center Borstel
Alere Technologies GmbH

Completed

Alere Mycobacterium Tuberculosis Urine Study

Tuberculosis

Germany
inSleep Technologies, LLC
Johns Hopkins University; Doctors Community Hospital; NeuroTrials Research, Inc.

Completed

Study of Nasal Airflow Pressure Optimization to Resolve Excessive Snoring (SNORE)

Snoring

United States
NanoString Technologies, Inc.
Hospital General Universitario Gregorio Marañon; Cedar Associates LLC; Illumina... and other collaborators

Completed

A Prospective Observational Study of Clinical Outcomes for the NanoString® Technologies Prosigna Gene Signature Assay

Breast Cancer

Spain
Research Center Borstel
Siemens Corporate Technologies

Completed

Siemens VOC TB Pilot Study

Tuberculosis

Germany
Michael Hoelscher
Quintiles, Inc.; German Federal Ministry of Education and Research; Parexel; European... and other collaborators

Completed

Early Bactericidal Activity (EBA) of SQ109 in Adult Subjects With Pulmonary TB (SQ109EBA)

Tuberculosis, Pulmonary

South Africa
University of Cape Town

Completed

Utility of Sputum Induction and Novel Technologies to Improve TB Diagnosis in a High HIV Prevalence Primary Care Setting (SINET)

Tuberculosis

South Africa
S.LAB (SOLOWAYS)
Center of New Medical Technologies

Not yet recruiting

Clinical Trial Protocol: Randomized Placebo-Controlled Pilot Study of GcMAF (Soloways TM) in Patients With Metastatic Breast Cancer

Breast Cancer

Russian Federation
Second Affiliated Hospital of Wenzhou Medical University

Not yet recruiting

MRD-positive Colorectal Cancer Patients Combined With Personalized Immune Regulation Diagnosis

Colorectal Cancer
Shanghai Pharmaceuticals Holding Co., Ltd

Not yet recruiting

A Clinical Study of SPH5030 Tablets in the Treatment of Her2-positive/Mutated Biliary Tract OR Colorectal Cancer Patients.

Biliary Tract or Colorectal Cancer With Her2-positive/Mutated

China
Jazz Pharmaceuticals

Not yet recruiting

A Phase 3, Randomized, Open-label, Controlled Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer

Metastatic HER2-positive Breast Cancer
Peking University Third Hospital
Bayer

Not yet recruiting

Efficacy and Safety of Darolutamide in Combination With Androgen-Deprivation Therapy in Prostate Cancer Patients With Lymph Node-positive After Radical Prostatectomy: A Prospective Observational Cohort Study

Prostate Cancer

China
Ohio State University

Recruiting

Incorporating Positive Affect Promoting Activities Into Cognitive Behavioral Therapies (PAPA)

Depression | Borderline Personality Disorder | Emotion Regulation

United States
Chia Tai Tianqing Pharmaceutical Group Nanjing...

Not yet recruiting

A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer

Biliary Tract Cancer

China
Baylor College of Medicine
OtoNexus Medical Technologies, Inc.

Recruiting

Utility of Advanced Ultrasound Otoscope In The Diagnosis of AOM

Middle Ear Infection | Ear Infection | Otitis Media Recurrent

United States
AstraZeneca

Not yet recruiting

A PROSPECTIVE, MULTI-CENTER, PHASE 4 STUDY TO ASSESS THE SAFETY OF TRASTUZUMAB DERUXTECAN, AN ANTI-HER2-ANTIBODY DRUG CONJUGATE IN INDIAN PATIENTS WITH UNRESECTABLE OR METASTATIC HER2-POSITIVE BREAST CANCER WHO HAVE RECEIVED A PRIOR ANTI-HER2-BASED REGIMEN (STRIDE)

BREAST CANCER
Zhongda Hospital

Recruiting

Personalized Ventilation Based on Ventilation-perfusion Mismatch and Lung Recruitability

Respiratory Distress Syndrome | Mechanical Ventilation | Positive-Pressure Respiration

China
Novartis Pharmaceuticals

Not yet recruiting

Clinical Study of Asciminib in Previously Treated Indian Patients With Ph+ CML-CP Without T315I Mutation and in Patients With Ph+ CML-CP With T315I Mutation (ASC4INDIA)

Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase
Boston Medical Center
Charles H. Hood Foundation

Not yet recruiting

A Novel Social Emotional Learning Curriculum for Youth With Epilepsy

Epilepsy

United States
BeiGene

Not yet recruiting

A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab, in Participants With Advanced or Metastatic Solid Tumors

Metastatic Solid Tumor | Advanced Hepatocellular Carcinoma | Metastatic Hepatocellular Carcinoma | Alpha-fetoprotein (AFP)-Producing Gastric Cancer | Extragonadal Yolk Sac Tumors | Glypican-3 (GPC3)-Positive Squamous Non-small Cell Lung Cancer
National Cancer Institute (NCI)

Not yet recruiting

Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR+ Gastrointestinal Neuroendocrine Tumor and Pheochromocytoma/Paraganglioma Previously Treated With Systemic Targeted Radioligand Therapy

Pheochromocytoma | Somatostatin Receptor Positive | Paragangliomas | Gastrointestinal Neuroendocrine Tumors

United States
Duygu Akyol
Başakşehir Çam & Sakura City Hospital

Not yet recruiting

Effect of Positive End-expiratory Pressure on Gastic Residual Volume

Pediatrics | Fasting Period
Gérond'if

Not yet recruiting

Cardiac Amyloidosis pRevaleNce of in OLDer Subjects Affected by Heart Failure (ARNOLD)

Cardiac Amyloidosis

France
Ascentage Pharma Group Inc.

Not yet recruiting

A Phase 3 Registrational Study of Olverembatinib (HQP1351) in Patients With CML (POLARIS-2)

Chronic Myeloid Leukemia | CML | CML, Chronic Phase

United States

Search clinical trials for: Positive Technologies

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Nigeria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations